Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v7-FR
Language English French
Date Updated 2022-09-27 2022-05-27
Drug Identification Number 02366479 02366479
Brand name REMIFENTANIL HYDROCHLORIDE FOR INJECTION REMIFENTANIL HYDROCHLORIDE FOR INJECTION
Common or Proper name REMIFENTANIL HYDROCHLORIDE FOR INJECTION REMIFENTANIL HYDROCHLORIDE FOR INJECTION
Company Name STERIMAX INC STERIMAX INC
Ingredients REMIFENTANIL REMIFENTANIL
Strength(s) 2MG 2MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 10 VIALS 10 VIALS
ATC code N01AH N01AH
ATC description ANESTHETICS, GENERAL ANESTHETICS, GENERAL
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2022-01-21 2022-01-21
Estimated end date Unknown Unknown
Actual end date 2022-07-26
Shortage status Resolved Actual shortage
Tier 3 Status No Yes
Company comments Product is on allocation at 100% at McKesson. Product is on allocation at 100% at McKesson.
Health Canada comments